James Shin
Stock Analyst at Deutsche Bank
(3.29)
# 1,059
Out of 5,044 analysts
22
Total ratings
60%
Success rate
16.46%
Average return
Main Sectors:
Top Industries:
Stocks Rated by James Shin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly and Company | Maintains: Buy | $1,010 → $900 | $820.10 | +9.74% | 5 | Aug 11, 2025 | |
| IMTX Immatics | Initiates: Buy | $10 | $10.35 | -3.38% | 1 | May 28, 2025 | |
| GILD Gilead Sciences | Upgrades: Buy | $80 → $120 | $117.88 | +1.80% | 2 | Feb 18, 2025 | |
| MRK Merck & Co. | Downgrades: Hold | $128 → $105 | $87.03 | +20.65% | 2 | Feb 18, 2025 | |
| AMGN Amgen | Reiterates: Hold | $310 → $305 | $292.09 | +4.42% | 2 | Aug 7, 2024 | |
| INCY Incyte | Maintains: Hold | $55 → $60 | $91.65 | -34.53% | 2 | Aug 1, 2024 | |
| BMY Bristol-Myers Squibb Company | Maintains: Hold | $53 → $45 | $42.82 | +5.09% | 3 | Jul 23, 2024 | |
| LEGN Legend Biotech | Initiates: Buy | $60 | $32.57 | +84.22% | 1 | May 23, 2024 | |
| ABBV AbbVie | Initiates: Hold | $150 | $227.54 | -34.08% | 1 | Nov 9, 2023 | |
| REGN Regeneron Pharmaceuticals | Initiates: Hold | $800 | $654.48 | +22.23% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.54 | +549.35% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.11 | +985.97% | 1 | Nov 9, 2023 |
Eli Lilly and Company
Aug 11, 2025
Maintains: Buy
Price Target: $1,010 → $900
Current: $820.10
Upside: +9.74%
Immatics
May 28, 2025
Initiates: Buy
Price Target: $10
Current: $10.35
Upside: -3.38%
Gilead Sciences
Feb 18, 2025
Upgrades: Buy
Price Target: $80 → $120
Current: $117.88
Upside: +1.80%
Merck & Co.
Feb 18, 2025
Downgrades: Hold
Price Target: $128 → $105
Current: $87.03
Upside: +20.65%
Amgen
Aug 7, 2024
Reiterates: Hold
Price Target: $310 → $305
Current: $292.09
Upside: +4.42%
Incyte
Aug 1, 2024
Maintains: Hold
Price Target: $55 → $60
Current: $91.65
Upside: -34.53%
Bristol-Myers Squibb Company
Jul 23, 2024
Maintains: Hold
Price Target: $53 → $45
Current: $42.82
Upside: +5.09%
Legend Biotech
May 23, 2024
Initiates: Buy
Price Target: $60
Current: $32.57
Upside: +84.22%
AbbVie
Nov 9, 2023
Initiates: Hold
Price Target: $150
Current: $227.54
Upside: -34.08%
Regeneron Pharmaceuticals
Nov 9, 2023
Initiates: Hold
Price Target: $800
Current: $654.48
Upside: +22.23%
Nov 9, 2023
Initiates: Buy
Price Target: $10
Current: $1.54
Upside: +549.35%
Nov 9, 2023
Initiates: Buy
Price Target: $12
Current: $1.11
Upside: +985.97%